SHLD Stock Overview
Through its subsidiaries, develops, manufactures, and sells a range of diagnostic and therapeutic products and services to healthcare providers worldwide.
Snowflake Score | |
---|---|
Valuation | 3/6 |
Future Growth | 3/6 |
Past Performance | 5/6 |
Financial Health | 2/6 |
Dividends | 2/6 |
Siemens Healthineers AG Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | €52.16 |
52 Week High | €57.46 |
52 Week Low | €44.86 |
Beta | 0.73 |
1 Month Change | -1.32% |
3 Month Change | -7.16% |
1 Year Change | 0.54% |
3 Year Change | 4.76% |
5 Year Change | 37.77% |
Change since IPO | 72.23% |
Recent News & Updates
Recent updates
Shareholder Returns
SHLD | GB Medical Equipment | GB Market | |
---|---|---|---|
7D | -5.0% | -1.9% | 0.4% |
1Y | 0.5% | -11.1% | 5.6% |
Return vs Industry: SHLD exceeded the UK Medical Equipment industry which returned -11.1% over the past year.
Return vs Market: SHLD underperformed the UK Market which returned 5.6% over the past year.
Price Volatility
SHLD volatility | |
---|---|
SHLD Average Weekly Movement | n/a |
Medical Equipment Industry Average Movement | 7.0% |
Market Average Movement | 4.8% |
10% most volatile stocks in GB Market | 11.0% |
10% least volatile stocks in GB Market | 2.8% |
Stable Share Price: SHLD has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine SHLD's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
n/a | 71,400 | Bernd Montag | www.siemens-healthineers.com |
Siemens Healthineers AG, through its subsidiaries, develops, manufactures, and sells a range of diagnostic and therapeutic products and services to healthcare providers worldwide. It operates through four segments: Imaging, Diagnostics, Varian, and Advanced Therapies. The Imaging segment provides magnetic resonance imaging, computed tomography, X-ray systems, molecular imaging, and ultrasound systems.
Siemens Healthineers AG Fundamentals Summary
SHLD fundamental statistics | |
---|---|
Market cap | €58.51b |
Earnings (TTM) | €1.84b |
Revenue (TTM) | €21.87b |
31.8x
P/E Ratio2.7x
P/S RatioIs SHLD overvalued?
See Fair Value and valuation analysisEarnings & Revenue
SHLD income statement (TTM) | |
---|---|
Revenue | €21.87b |
Cost of Revenue | €13.67b |
Gross Profit | €8.20b |
Other Expenses | €6.36b |
Earnings | €1.84b |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
Jul 31, 2024
Earnings per share (EPS) | 1.65 |
Gross Margin | 37.50% |
Net Profit Margin | 8.41% |
Debt/Equity Ratio | 76.4% |
How did SHLD perform over the long term?
See historical performance and comparison